AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Milting, H El Banayosy, A Kassner, A Fey, O Sarnowski, P Arusoglu, L Thieleczek, R Brinkmann, T Kleesiek, K Korfer, R
Citation: H. Milting et al., The time course of natriuretic hormones as plasma markers of myocardial recovery in heart transplant candidates during ventricular assist device support reveals differences among device types, J HEART LUN, 20(9), 2001, pp. 949-955

Authors: Hirata, N Koerner, MM Tenderich, G Minami, K Mannebach, H Kleesiek, K Koerfer, R
Citation: N. Hirata et al., Influence of cytoimmunological state on the development of tuberculosis inheart transplant recipients, SURG TODAY, 31(6), 2001, pp. 482-486

Authors: Mirow, N Brinkmann, T Minami, K Tenderich, G Kleesiek, K Korfer, R
Citation: N. Mirow et al., Heparin-coated extracorporeal circulation with full and low dose heparinization: Comparison of thrombin related coagulatory effects, ARTIF ORGAN, 25(6), 2001, pp. 480-485

Authors: Mirow, N Brinkmann, T Minami, K Tenderich, G Schulte-Eistrup, S Kleesiek, K Korfer, R
Citation: N. Mirow et al., Low dose systemic heparinization combined with heparin-coated extracorporeal circulation - Effects related to platelets, J CARD SURG, 42(5), 2001, pp. 579-585

Authors: Kuhn, J Gotting, C Schnolzer, M Kempf, T Brinkmann, T Kleesiek, K
Citation: J. Kuhn et al., First isolation of human UDP-D-xylose: Proteoglycan core protein beta-D-xylosyltransferase secreted from cultured JAR choriocarcinoma cells, J BIOL CHEM, 276(7), 2001, pp. 4940-4947

Authors: Wolff, C Diekmann, A Boomgaarden, M Korner, MM Kleesiek, K
Citation: C. Wolff et al., Viremia and excretion of TT virus in immunosuppressed heart transplant recipients and in immunocompetent individuals, TRANSPLANT, 69(3), 2000, pp. 351-356

Authors: Gotting, C Kuhn, J Zahn, R Brinkmann, T Kleesiek, K
Citation: C. Gotting et al., Molecular cloning and expression of human UDP-D-xylose : proteoglycan coreprotein beta-D-xylosyltransferase and its first isoform XT-II, J MOL BIOL, 304(4), 2000, pp. 517-528

Authors: Gotting, C Kuhn, J Sollberg, S Huerkamp, C Brinkmann, T Krieg, T Kleesiek, K
Citation: C. Gotting et al., Elevated serum xylosyltransferase activity correlates with a high level ofhyaluronate in patients with systemic sclerosis, ACT DER-VEN, 80(1), 2000, pp. 60-61

Authors: Kleesiek, K Schmidt, M Gotting, C Schwenz, B Lange, S Muller-Berghaus, G Brinkmann, T Prohaska, W
Citation: K. Kleesiek et al., The 536C -> T transition in the human tissue factor pathway inhibitor (TFPI) gene is statistically associated with a higher risk for venous thrombosis, THROMB HAEM, 82(1), 1999, pp. 1-5

Authors: Prohaska, W Schmidt, M Mannebach, H Gleichmann, U Kleesiek, K
Citation: W. Prohaska et al., The prevalence of the prothrombin 20210 G -> A mutation is not increased in angiographically confirmed coronary artery disease, THROMB HAEM, 81(1), 1999, pp. 161-162

Authors: Gotting, C Sollberg, S Kuhn, J Weilke, C Huerkamp, C Brinkmann, T Krieg, T Kleesiek, K
Citation: C. Gotting et al., Serum xylosyltransferase: a new biochemical marker of the sclerotic process in systemic sclerosis, J INVES DER, 112(6), 1999, pp. 919-924

Authors: Prohaska, W Korner, MM Koster-Eiserfunke, W Korfer, R Kleesiek, K
Citation: W. Prohaska et al., Immunologic monitoring for rejection diagnosis during the first three months after heart transplantation, INFUSIONSTH, 25(6), 1998, pp. 364-369
Risultati: 1-12 |